ARDELYX, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ARDELYX, INC. (ARDX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-02-19
- ARDELYX, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.20%, a 100.00% increase from fiscal 2024.
- ARDELYX, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.10%, a 75.00% decline from fiscal 2023.
- ARDELYX, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.40%.
- ARDELYX, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.80%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.20% 10-K · filed 2026-02-19 | |
| 2024-12-31 | 0.10% 10-K · filed 2026-02-19 | -0.60% 10-K · filed 2025-02-20 |
| 2023-12-31 | 0.40% 10-K · filed 2026-02-19 | 0.00% 10-K · filed 2024-02-22 |
| 2022-12-31 | -0.80% 10-K · filed 2025-02-20 | |
| 2021-12-31 | 0.00% 10-K · filed 2024-02-22 | |
| 2020-12-31 | -0.10% 10-K · filed 2023-03-02 | -0.60% 10-K · filed 2021-03-08 |
| 2019-12-31 | -0.40% 10-K · filed 2022-02-28 | |
| 2018-12-31 | 0.70% 10-K · filed 2021-03-08 | |
| 2017-12-31 | 0.10% 10-K · filed 2020-03-06 | -0.70% 10-K · filed 2018-03-14 |
| 2016-12-31 | 0.50% 10-K · filed 2019-03-06 | 0.60% 10-K · filed 2017-02-17 |
| 2015-12-31 | -1.70% 10-K · filed 2018-03-14 | |
| 2014-12-31 | -3.20% 10-K · filed 2017-02-17 | |
| 2013-12-31 | 0.30% 10-K · filed 2016-03-04 | |
| 2012-12-31 | 4.40% 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |